Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
DOI:
https://doi.org/10.3889/oamjms.2017.039Keywords:
peripheral blood hematopoietic stem cells, autologous stem cell transplantation, hematopoietic recovery, engraftmentAbstract
BACKGROUND: Successful hematopoietic stem cell transplantation (HSCT) requires a rapid and durable hematopoietic recovery.
AIM: The aim of our study was to analyse factors that influence hematopoietic recovery after autologous HSCT.
MATERIALS AND METHODS: Multiple regression analysis was used to analyse factors affecting neutrophil and platelet engraftment in 90 autologous transplanted patients – 30 with acute myeloid leukaemia (AML), 30 with lymphoma and 30 with multiple myeloma (MM) from 2008 till 2016.
RESULTS: The neutrophil recovery in AML patients was significantly influenced by transfusion support with random-donor platelets, sex and number of transplanted mononuclear cells (MNC) and CD34+ cells; and in lymphoma patients, it was influenced by sex, age, mobilisation strategy and some transplanted MNC. The influence of investigated factors on neutrophil engraftment in MM patients was not statistically significant. The platelet recovery in AML patients was influenced by transfusion support with random-donor platelets; in lymphoma patients, it was influenced by sex, age, time from diagnosis to harvesting and time from diagnosis to HSCT; and in MM patients it was influenced by transfusion support with random-donor platelets.
CONCLUSION: Additional studies are necessary to better understanding of engraftment kinetic to improve the safety of HSCT and to minimise potential complications and expenses related to HSCT.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Nivison-Smith I, Bardy P, Doddset AJ et al. A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant. 2016; 22(2):284-91. https://doi.org/10.1016/j.bbmt.2015.09.009 PMid:26385524
Urbano-Ispizua A, Schmitz N, de Witte T et al. Allogeneic and autologous transplantation for haematologic diseases, solid tumors and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2002;29:639–46. https://doi.org/10.1038/sj.bmt.1703535 PMid:12180107
Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C et al. for the European Society for Blood and Marrow Transplantation. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015; 50: 1037–56. https://doi.org/10.1038/bmt.2015.6 PMid:25798672
Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI et al. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015; 21(11): 1863-69. https://doi.org/10.1016/j.bbmt.2015.07.032 PMid:26256941 PMCid:PMC4830270
EBMT - European Group for Blood and Bone Marrow Transplantation. Annual Report 2016, available at: www.ebmt.org
Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2016. CIBMTR-Center for International Bone Marrow Transplantation Research, available at: http://www.cibmtr.org
Gonclves TL, Benvegnu DM, Bonfanti G. Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation. Oxid Med Cell Longev. 2009; 2(2): 82-87. https://doi.org/10.4161/oxim.2.2.8355
Grathwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology. Haematologica. 2010; 95(4): 637-43. https://doi.org/10.3324/haematol.2009.015586 PMid:20378578 PMCid:PMC2857194
Grubovic R, Georgievski B, Cevreska L, Genadieva Stavric S, Grubovic M. Evaluation of factors that influence hematopoietic recovery in patients transplanted with peripheral blood derived stem cells. Bilt Transfuziol. 2016;62(1-2):29-37.
Larghero J, Garcia J, Gluckman E. Sources and procurement of HSC. In: Appaerley J, Carreras E, Gluckman E, Gratwohl A, MaÃzi T, editors. Haemopoietic Stem Cell Transplantation. The EBMT Handbook, Revised ed. ESH; 2008: 112-27.
Henon PR, Liang H, Beck-Wirth G, Eisenmann JC, Lepers M, Wunder E, Kandel G. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 1992; 9(4): 285-91. PMid:1376185
Raos M, Nemet D, Bojanic I, et al. Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome. Coll Antropol. 2010:34(1): 105–15. PMid:20437639
Carral A, de la Rubia J, Martan G, Martanez J, Sanz G, Jarque I, et al. Factors influencing hematopoietic recovery after blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Bone Marrow Transplant. 2002;29:825–32. https://doi.org/10.1038/sj.bmt.1703566 PMid:12058232
Horning SJ, Nademanee AP. Autologous hematopoietic cell transplantation for non- Hodgkin lymphoma. Blackwell Science, 1999; 939-51.
Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813–26. https://doi.org/10.1056/NEJMra052638 PMid:16641398
Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle H, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol. 1995;13:1328–35. https://doi.org/10.1200/JCO.1995.13.6.1328 PMid:7538556
Tayebi H, Lapierre V, Saas P, Lienard A, Sutton L, Milpied N, et al. Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft. Br J Haematol. 2001;114:698–700. https://doi.org/10.1046/j.1365-2141.2001.02965.x PMid:11553000
Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transportation. Blood. 2000;95:3702–09. PMid:10845900
Rizzo JD. Current trends in BMT. ABMTR News Letter 1998; 5:4-10.
Turk HM, Komurcu S, Arpaci F, Ozet A, Kilic S, Kuzhan O et al. Factors affecting engraftment time in autologous peripheral stem cell transplantation. Asian Pac J Cancer Prev. 2010; 11(3): 697-702. PMid:21039038
Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, Gernsheimer T, Holcomb JB, Kaplan LJ, Katz LM, Peterson N, Ramsey G, Rao SV, Roback JD, Shander A, Tobian AAR. Clinical Practice Guidelines from the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316(19):2025-35. https://doi.org/10.1001/jama.2016.9185 PMid:27732721
Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet Transfusion: A Clinical Practice Guideline from the AABB. Ann Intern Med. 2015;162:205-13. https://doi.org/10.7326/M14-1589 PMid:25383671
Sutherland DR, Anderson L, Keeney M, for the International Society of Hematotherapy and Graft Engineering, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996;(5):213–26. https://doi.org/10.1089/scd.1.1996.5.213 PMid:8817388
Olivieri A, Offidani M, Montanari M, Ciniero L, Cantori I, Ombrosi L et al. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica. 1998; 83(4):329-37. PMid:9592983
Villalon L, Odriozola J, Larana JG, Zamora C, Perez de Oteyza J, Jodra MH et al. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J. 2000; 1(6):374-81. https://doi.org/10.1038/sj.thj.6200057 PMid:11920217
Ergene U, Cagirgan S, Pehlivan M, Yilmaz M, Tombuloglu M. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT). Transfus Apher Sci. 2007; 36(1): 23-29. https://doi.org/10.1016/j.transci.2006.08.009 PMid:17292672
Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J et al. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent 2207-16.
Alshemmari SH, Ameen RM, Gyrafas J, Alqallaf DA, Sajnani KP. Factors influencing engraftment in autologous peripheral stem cell transplantation. The experience of a local Kuwaiti transplantation center. Saudi Med J. 2007; 28(7): 1080-85. PMid:17603716
Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 1995; 85(2): 588-96. PMid:7529066
Ungerstedt JS, Watz E, Uttervall K, JohanssonBM, Wahlin BE, Nasman P et al. Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery. Med Oncol. 2012; 29(3): 2191-99. https://doi.org/10.1007/s12032-011-0029-3 PMid:21779930
Yuan S, Palmer JM, Tsai NC, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor. Hematol Oncol. 2016. https://doi.org/10.1002/hon.2286 PMid:26928577
Liesveld J, Pawlowski J, Chen R, Hyrien O, Debolt J, Becker M, Phillips G 2nd, Chen Y. Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis. Bone Marrow Transplant. 2013; 48(5): 691-97. https://doi.org/10.1038/bmt.2012.194 PMid:23085827
Ganguly S, Bradley JP, Patel JS, Tilzer L. Role of transfusion in stem cell transplantation: a freedom-from-transfusion (FFT), cost and survival analysis. J Med Econ. 2010;13(1):55-62. https://doi.org/10.3111/13696990903540602 PMid:20017589
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
